Literature DB >> 24447534

Pharmacokinetics of a novel orodispersible tablet of sildenafil in healthy subjects.

Bharat Damle1, Gregory Duczynski2, Barrett W Jeffers3, Penelope Crownover3, Alastair Coupe4, Robert R LaBadie2.   

Abstract

BACKGROUND: Sildenafil citrate is indicated for the treatment of erectile dysfunction. An orally disintegrating tablet (ODT) of sildenafil citrate has been developed for the benefit of patients who have difficulty swallowing solid dosage forms.
OBJECTIVE: The main goal of this study was to evaluate the bioequivalence of sildenafil ODT with and without water versus marketed sildenafil oral film-coated tablets. A secondary objective was to evaluate the effects of a high-fat meal on the pharmacokinetics of sildenafil ODT.
METHODS: The bioequivalence study of sildenafil ODT given with and without water versus marketed sildenafil citrate film-coated oral tablets was conducted in 36 subjects. In a food-effect study, the effect of a standard high-fat meal on the pharmacokinetics of sildenafil ODT was evaluated in 12 subjects. Both studies were randomized, open-label, crossover, single-dose (50 mg) studies in healthy men aged ≥45 years. Plasma samples were collected for 14 hours postdose, and pharmacokinetics were determined by using noncompartmental analyses.
RESULTS: All subjects in both studies were Asian males between the ages of 45 and 69 years. Sildenafil ODT without water was bioequivalent to the marketed sildenafil film-coated oral tablet as the 90% CI for the ratio of geometric means of Cmax, AUC0-∞, and AUC0-last were contained within equivalence limits (80%-125%). When sildenafil ODTs were given with water, the 90% CIs for sildenafil AUC0-∞ and AUC0-last were contained within the range of 80% to 125%; however, the 90% CI for sildenafil Cmax was not (79.76-92.78). This difference in Cmax is unlikely to have any clinically meaningful impact. High-fat meals reduced the rate but not the extent of absorption of sildenafil. Mean Cmax was reduced by 59%, and median Tmax was delayed from 0.625 hour (fasting) to 4 hours (high-fat meal). However, AUC values were comparable between fed and fasted treatments.
CONCLUSIONS: Sildenafil ODT, given with or without water, provides equivalent systemic exposure compared with marketed sildenafil film-coated oral tablets, thus offering a convenient alternative method of administration. Considering the results of the food-effect study, sildenafil ODT should be taken on an empty stomach. ClinicalTrials.gov identifiers: NCT01254383 (bioequivalence) and NCT01254396 (food effect).
Copyright © 2014 Elsevier HS Journals, Inc. All rights reserved.

Entities:  

Keywords:  orodispersible tablet; pharmacokinetics; sildenafil.

Mesh:

Substances:

Year:  2014        PMID: 24447534     DOI: 10.1016/j.clinthera.2013.12.010

Source DB:  PubMed          Journal:  Clin Ther        ISSN: 0149-2918            Impact factor:   3.393


  8 in total

1.  Optimized nano-transfersomal films for enhanced sildenafil citrate transdermal delivery: ex vivo and in vivo evaluation.

Authors:  Shaimaa M Badr-Eldin; Osamaa Aa Ahmed
Journal:  Drug Des Devel Ther       Date:  2016-04-05       Impact factor: 4.162

Review 2.  Needs and Expectations of Patients with Erectile Dysfunction: An Update on Pharmacological Innovations in Phosphodiesterase Type 5 Inhibition with Focus on Sildenafil.

Authors:  Emmanuele A Jannini; Stéphane Droupy
Journal:  Sex Med       Date:  2018-12-03       Impact factor: 2.491

Review 3.  The first-generation phosphodiesterase 5 inhibitors and their pharmacokinetic issue.

Authors:  A Zucchi; E Costantini; F I Scroppo; M Silvani; Z Kopa; E Illiano; M G Petrillo; L Cari; G Nocentini
Journal:  Andrology       Date:  2019-07-26       Impact factor: 3.842

Review 4.  Sildenafil 4.0-Integrated Synthetic Chemistry, Formulation and Analytical Strategies Effecting Immense Therapeutic and Societal Impact in the Fourth Industrial Era.

Authors:  Andreas Ouranidis; Anastasia Tsiaxerli; Elisavet Vardaka; Catherine K Markopoulou; Constantinos K Zacharis; Ioannis Nicolaou; Dimitris Hatzichristou; Anna-Bettina Haidich; Nikolaos Kostomitsopoulos; Kyriakos Kachrimanis
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-15

5.  Investigation of the bioequivalence of montelukast chewable tablets after a single oral administration using a validated LC-MS/MS method.

Authors:  Abdel Naser Zaid; Murad N Abualhasan; David G Watson; Ayman Mousa; Nadia Ghazal; Rana Bustami
Journal:  Drug Des Devel Ther       Date:  2015-09-23       Impact factor: 4.162

6.  Interchangeability and comparative effectiveness between generic and brand montelukast immediate release tablets after a single oral administration in healthy volunteers.

Authors:  Abdel Naser Zaid; Ayman Mousa; Nadia Ghazal; Rana Bustami
Journal:  Clin Transl Allergy       Date:  2015-11-11       Impact factor: 5.871

7.  Bioequivalence and Bioavailability of an Orodispersible Tablet of Sildenafil Citrate in Healthy Chinese Male Subjects.

Authors:  Yuan Lv; Bin-Yu Luo; Robert R LaBadie; Hua Zhu; Yan Feng; Cynthia Ernst; Penelope H Crownover; Yali Liang; Qinying Zhao
Journal:  Clin Pharmacol Drug Dev       Date:  2020-05-28

Review 8.  Novel Emerging Therapies for Erectile Dysfunction.

Authors:  Soyeun Kim; Min Chul Cho; Sung Yong Cho; Hong Chung; Mahadevan Raj Rajasekaran
Journal:  World J Mens Health       Date:  2020-03-16       Impact factor: 5.400

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.